Factors Influencing the Success of BCG Vaccination in Cattle

The effectiveness of BCG vaccination against bovine tuberculosis (bTB) depends on more than vaccine administration alone. Protection can be influenced by several animal-, vaccine-, and management-related factors. Understanding these variables allows veterinarians to optimize vaccination protocols, set realistic expectations, and achieve better long-term disease control. While no single factor determines vaccine success, careful attention to multiple aspects of herd health can improve overall outcomes^1,2. 

Animal-Related Factors 

Age at Vaccination 

BCG vaccination has demonstrated protective effects in cattle vaccinated at different ages. However, vaccinating calves before significant exposure to environmental mycobacteria may provide an advantage by reducing potential interference with the immune response¹. 

Exposure to Environmental Mycobacteria 

Naturally occurring environmental mycobacteria can influence vaccine-induced immunity. Prior exposure to these organisms may interfere with the protective immune response generated by BCG, potentially reducing vaccine efficacy under field conditions¹. 

Immune Status 

An effective immune response is essential for successful vaccination. Animals receiving corticosteroid treatment or those with compromised immune function may develop a weaker response following vaccination. Whenever possible, vaccination should be planned when cattle are in good health and capable of mounting an adequate immune response². 

Vaccine-Related Factors 

Vaccine Strain 

Several BCG strains, including Danish, Pasteur, Tokyo, Russian, and Phipps, have demonstrated protective efficacy in cattle. Current evidence does not indicate a clear superiority of one strain over another, suggesting that multiple licensed strains can provide comparable protection when used appropriately^1,3,4,5. 

Dose and Route of Administration 

Both the vaccine dose and route of administration influence protective outcomes. 

Subcutaneous administration remains the preferred field route because it is practical and has consistently produced favorable immune responses¹. 

Moderate doses of approximately 1 × 10⁶ CFU administered subcutaneously have shown effective protection against pathological lesions, whereas very high parenteral doses have demonstrated lower protective efficacy¹. 

Booster Vaccination 

Protection following BCG vaccination is estimated to persist for approximately one to two years. Protein-based booster vaccination has demonstrated the ability to enhance immunity and may improve the duration of protection where incorporated into vaccination protocols¹. 

Herd and Management Factors 

Infection Pressure 

The level of disease exposure within a herd can influence vaccination outcomes. Herds with a high infection burden may require vaccination alongside additional disease-control measures to reduce transmission and improve long-term effectiveness¹. 

Long-Term Program Implementation 

Vaccination should be viewed as part of an ongoing herd health strategy rather than a one-time intervention. Regular herd monitoring, clearly defined control objectives, and periodic evaluation of disease status help maximize the benefits of vaccination over time¹. 

Practical Clinical Insights 

Veterinarians can improve vaccination success by evaluating factors that may reduce immune protection before implementing a vaccination program. Reviewing herd health, minimizing unnecessary corticosteroid use around vaccination, selecting an appropriate vaccination protocol, and maintaining good herd management practices can all contribute to more consistent outcomes. 

Equally important is setting realistic expectations with producers. BCG vaccination reduces disease severity and transmission but performs best when incorporated into a comprehensive tuberculosis control program. 

Take-Home Message 

The success of BCG vaccination depends on multiple interacting factors, including animal age, immune status, environmental mycobacterial exposure, vaccine strain, dose, route of administration, and herd-level disease pressure. Recognizing these influences allows veterinarians to optimize vaccination protocols and improve the long-term effectiveness of bovine tuberculosis control programs while supporting practical herd management. 

Reference 

1. Milián-Suazo F, González-Ruiz S, Contreras-Magallanes YG, Sosa-Gallegos SL, Bárcenas-Reyes I, Cantó-Alarcón GJ, Rodríguez-Hernández E. Vaccination strategies in a potential use of the vaccine against bovine tuberculosis in infected herds. Animals. 2022 Dec 1;12(23):3377. https://www.mdpi.com/2076-2615/12/23/3377 

2. Buddle BM, Vordermeier HM, Chambers MA, de Klerk-Lorist LM. Efficacy and safety of BCG vaccine for control of tuberculosis in domestic livestock and wildlife. Frontiers in veterinary science. 2018 Oct 26;5:259. https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2018.00259/full 

3. Balseiro A, Prieto JM, Álvarez V, Lesellier S, Davé D, Salguero FJ, Sevilla IA, Infantes-Lorenzo JA, Garrido JM, Adriaensen H, Juste RA. Protective effect of oral BCG and inactivated Mycobacterium bovis vaccines in European badgers (Meles meles) experimentally infected with M. bovis. Frontiers in veterinary science. 2020 Feb 4;7:485289. https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2020.00041/full?show=full 

4. Canto Alarcon GJ, Rubio Venegas Y, Bojorquez Narvaez L, Pizano Martínez OE, García Casanova L, Sosa Gallegos S, Nava Vargas A, Olvera Ramírez AM, Milian Suazo F. Efficacy of a vaccine formula against tuberculosis in cattle. PLoS One. 2013 Oct 18;8(10):e76418. https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0076418&type=printable 

5. Ameni G, Tafess K, Zewde A, Eguale T, Tilahun M, Hailu T, Sirak A, Salguero FJ, Berg S, Aseffa A, Hewinson RG. Vaccination of calves with Mycobacterium bovis Bacillus Calmette–Guerin reduces the frequency and severity of lesions of bovine tuberculosis under a natural transmission setting in Ethiopia. Transboundary and emerging diseases. 2018 Feb;65(1):96-104. https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbed.12618